» Articles » PMID: 39259087

Smoking Cessation and Risk of Metabolic Syndrome: A Meta-analysis

Overview
Specialty General Medicine
Date 2024 Sep 11
PMID 39259087
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Smoking is an important risk factor for various metabolic and cardiovascular disorders, and smoking cessation reduces the risk of these conditions. However, weight gain is commonly observed when individuals quit smoking, which often leads to hesitation in pursuing smoking cessation. Weight gain increases the risk of metabolic syndrome (MS). However, previous studies that investigated the relationship between smoking cessation and MS have yielded inconsistent results. Therefore, we conducted a meta-analysis to evaluate the association between smoking cessation and MS.

Methods: Medline, Embase, Cochrane Library and CINAHL databases, were comprehensively searched from inception to April 2023, to identify relevant studies examining the relationship between smoking cessation and MS, comparing such relationship to that with active smoking. The methodological quality of the selected studies was assessed using the Newcastle-Ottawa Quality Assessment Scale. A random-effects model was used for meta-analysis.

Results: Of 495 identified studies, 24 were reviewed. The risk of selection bias was identified in all the studies. The overall analysis of 14 studies, including data of combined results for both men and women, revealed an increased risk of MS among ex-smokers compared with that among active smokers (pooled relative risk [RR] 1.18, 95% confidence interval [CI]: 1.08-1.29). From the selected studies, 13 studies analyzing men were extracted for subgroup analysis. Among men, no significant difference in the risk of developing MS was observed between ex-smokers and smokers (pooled RR: 1.05, 95% CI: 0.95-1.17). In men, the risk of MS increased if the cessation period was ≤15 years in men (pooled RR 1.26, 95% CI: 1.01-1.56) and slightly decreased if the cessation period was > 15 years (RR 0.84, 95% CI: 0.70-1.00) in ex-smokers compared with that in current smokers.

Conclusion: An increased risk of MS was observed in the early stages of smoking cessation compared with current smoking. As the longer duration of smoking cessation, the risk of MS becomes less significant.

Citing Articles

Body Fat and Visceral Fat Values in Spanish Healthcare Workers: Associated Variables.

Tarraga Marcos P, Lopez-Gonzalez A, Martinez-Almoyna Rifa E, Paublini Oliveira H, Martorell Sanchez C, Tarraga Lopez P Nutrients. 2025; 17(4).

PMID: 40004977 PMC: 11858298. DOI: 10.3390/nu17040649.


Etiology, Pathophysiology, and Treatment Strategies in the Prevention and Management of Metabolic Syndrome.

Patial R, Batta I, Thakur M, Sobti R, Agrawal D Arch Intern Med Res. 2024; 7(4):273-283.

PMID: 39574946 PMC: 11580789. DOI: 10.26502/aimr.0184.

References
1.
Suutari-Jaasko A, Ylitalo A, Ronkaine J, Huikuri H, Kesaniemi Y, Ukkola O . Smoking cessation and obesity-related morbidities and mortality in a 20-year follow-up study. PLoS One. 2022; 17(12):e0279443. PMC: 9797072. DOI: 10.1371/journal.pone.0279443. View

2.
Shin H, Oh J, Cho Y . The Association Between Smoking Cessation Period and Metabolic Syndrome in Korean Men. Asia Pac J Public Health. 2018; 30(5):415-424. DOI: 10.1177/1010539518786517. View

3.
Al-Daghri N . Acute post cessation smoking. A strong predictive factor for metabolic syndrome among adult Saudis. Saudi Med J. 2009; 30(2):267-71. View

4.
Kar D, Gillies C, Zaccardi F, Webb D, Seidu S, Tesfaye S . Relationship of cardiometabolic parameters in non-smokers, current smokers, and quitters in diabetes: a systematic review and meta-analysis. Cardiovasc Diabetol. 2016; 15(1):158. PMC: 5121966. DOI: 10.1186/s12933-016-0475-5. View

5.
Zhu Y, Zhang M, Hou X, Lu J, Peng L, Gu H . Cigarette smoking increases risk for incident metabolic syndrome in Chinese men-Shanghai diabetes study. Biomed Environ Sci. 2011; 24(5):475-82. DOI: 10.3967/0895-3988.2011.05.004. View